Vibcare Pharma is a Top Pharma Franchise Company in India

Vibcare Pharma has a reputation for offering incredible PCD pharma franchise opportunities.
Jan 25, 2020 Mark

Press Release (ePRNews.com) - India - Jan 25, 2020 - Vibcare Pharma is a growing PCD Pharma company based in India. The company is on a mission to develop, produce and market affordable pharmaceutical products in domestic, as well as CIS, African and South Asian, markets. The purpose behind is to make quality backed healthcare easily accessible to all. By improving and enhancing the offerings, maintaining quality standards and cost-efficacy at all times, Vibcare Pharma envisions becoming a leading pharmaceutical player in the industry. Doing its work well and being there in the industry for 40 years, Vibcare Pharma already enjoys a formidable reputation.

While answering a query related to Vibcare Pharma, the company spokesperson stated, “We aim to do things that can help make quality backed and competitively priced healthcare easily available to the masses. We believe it is our responsibility to deliver quality healthcare services to all segments of society, without compromising our core values of integrity, good ethics and commitment. Thus, we put consistent efforts to improve our products, processes and systems. Besides making a portfolio of low-cost medicines available to all, we specialize in offering pharma franchise and PCD pharma opportunities in India.”

Profound industry experience is quite evident in all Vibcare Pharma operations and offerings. The company offers over 500 different products in over 6 therapeutic segments, which are all manufactured in ISO 9001 2015 WHO GMP certified facilities. Having its own state-of-the-art facilities, the company manages to maintain quality controls all the time. Product categories available on the Vibcare Pharma website include syrup, tube, lotion capsule, tablets, pediatric, injectable, gel, soap, protein powder and sachet, eye drop, ointment, nasal drop and softgel. Order placement online is easy and so is order tracking.

The spokesperson added, “We provide third-party manufacturing of over 500 products and our process starts with finalizing order quantity and composition of the product. We have to keep in mind minimum order quantities for the composition while concluding the order quantity. MOQ for tablets and capsules is usually between 500 and 1000 Boxes, i.e. 50000-100000 tablets. After finalizing composition and order quantities for contract manufacturing, we raise a quotation that includes all the costs the client will incur. Then we produce products using GMP (Good Manufacturing Practices) and WHO guidelines. This confirms that we create products using correct procedures that are reliable.”

Vibcare Pharma can be an ideal choice for those looking for PCD pharma company in India. Being one of the best pharma franchise companies, it has designed a special PCD Pharma program that enables Vibcare to provide the best pharma franchise and PCD Pharma to customers.

About Vibcare Pharma:

Vibcare Pharma is a reputable company that strives to make high-quality healthcare affordable and easily accessible to all. Vibcare Pharma also enjoys a reputation for being the best PCD company and has set benchmarks in terms of providing unmatched PCD pharma franchise opportunities.

Contact Information:

Vibcare Pharma Pvt. Ltd.

Plot No 4, HSIIDC IT Park

Sector 22, Panchkula

Haryana – 134109

Phone: 9888988858

Email: info@vibcare.co.in

Website: www.vibcare.co.in

 

Source : Vibcare Pharma Pvt. Ltd. Follow on Google News
CATEGORIES : Healthcare
SHARE :  

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login

DISCLAIMER

If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.